PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsUrea c-14
Urea c-14
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
57 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Stomach neoplasmsD013274EFO_0003897C161——2—3
Helicobacter infectionsD016481EFO_1000961————213
GastritisD005756EFO_0000217K29.7———2—2
InfectionsD007239EFO_0000544————1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223—C85.98141—222
Follicular lymphomaD008224—C82351—17
Hepatocellular carcinomaD006528—C22.0—11——2
Liver neoplasmsD008113EFO_1001513C22.0—11——2
HepatoblastomaD018197—C22.2——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-hodgkin lymphomaD008228—C85.989——114
B-cell lymphomaD016393——66——110
Hodgkin diseaseD006689—C8144——28
Large b-cell lymphoma diffuseD016403—C83.355——18
Mantle-cell lymphomaD020522—C83.145——17
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.033——17
LeukemiaD007938—C9525———7
T-cell lymphomaD016399——22——14
Multiple myelomaD009101—C90.032———4
Burkitt lymphomaD002051—C83.721——14
Show 32 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myeloid leukemia acuteD015470—C92.03————3
T-cell lymphoma cutaneousD016410—C84.A1———12
B-cell chronic lymphocytic leukemiaD015451—C91.11———12
Plasma cell leukemiaD007952—C90.11————1
Myeloid leukemiaD007951—C921————1
Castleman diseaseD005871EFO_1001332D47.Z21————1
Central nervous system neoplasmsD016543——1————1
Type 1 diabetes mellitusD003922EFO_0001359E101————1
Hematologic neoplasmsD019337——1————1
Colorectal neoplasmsD015179——1————1
Show 8 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Extranodal nk-t-cell lymphomaD054391—C86.0————11
Sezary syndromeD012751—C84.1————11
B-cell lymphoma marginal zoneD018442—C88.4————11
Waldenstrom macroglobulinemiaD008258—C88.0————11
Large-cell lymphoma anaplasticD017728—C84.6————11
Immunoblastic lymphadenopathyD007119EFO_1001350C86.5————11
Mycosis fungoidesD009182—C84.0————11
Adult t-cell leukemia-lymphomaD015459—C91.5————11
Hairy cell leukemiaD007943—C91.4————11
Intraocular lymphomaD064090——————11
Show 8 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 434 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use